000			02215 a2200589 4500
005			20250516105259.0
264		0	_c20130117
008			201301s 0 0 eng d
022			_a1556-1380
024	7		_a10.1097/JTO.0b013e318260de8b _2doi
040			_aNLM _beng _cNLM
100	1		_aMaemondo, Makoto
245	0	0	_aFirst-line gefitinib in patients aged 75 or older with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations: NEJ 003 study. _h[electronic resource]
260			_bJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _cSep 2012
300			_a1417-22 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCarcinoma, Adenosquamous _xdrug therapy
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aErbB Receptors _xantagonists & inhibitors
650	0	4	_aFeasibility Studies
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGefitinib
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMutation _xgenetics
650	0	4	_aNeoplasm Staging
650	0	4	_aPrognosis
650	0	4	_aQuinazolines _xtherapeutic use
650	0	4	_aSurvival Rate
700	1		_aMinegishi, Yuji
700	1		_aInoue, Akira
700	1		_aKobayashi, Kunihiko
700	1		_aHarada, Masao
700	1		_aOkinaga, Shoji
700	1		_aMorikawa, Naoto
700	1		_aOizumi, Satoshi
700	1		_aTanaka, Tomoaki
700	1		_aIsobe, Hiroshi
700	1		_aKudoh, Shoji
700	1		_aHagiwara, Koichi
700	1		_aNukiwa, Toshihiro
700	1		_aGemma, Akihiko
700	1		_aGemmah, Akihiko
773	0		_tJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _gvol. 7 _gno. 9 _gp. 1417-22
856	4	0	_uhttps://doi.org/10.1097/JTO.0b013e318260de8b _zAvailable from publisher's website
999			_c22026942 _d22026942